Differential effects of 5-azacytidine and 5-azadeoxycytidine on cytotoxicity, DNA-strand breaking and repair of X-ray-induced DNA damage in HeLa cells.
The cytotoxicity, DNA-strand breaking ability, and effects on repair of X-ray-induced DNA damage by short treatments with 5-azacytidine (azaCyd) and 5-azadeoxycytidine (azadCyd) were examined in HeLa cells. azaCyd was shown to be an effective inhibitor of the repair of X-ray-induced DNA single-strand breaks whereas azadCyd did not have this effect. At high doses, both compounds also induced DNA damage by themselves. The cytotoxicity, inhibition of repair, and drug-induced DNA damage associated with azaCyd treatment were all reversed by the concurrent addition to the cells of cytidine or uridine but not by thymidine, deoxycytidine or deoxyuridine. Cytotoxicity and drug-induced strand breaks associated with azadCyd treatment were reversed to varying degrees with all nucleosides and deoxynucleosides. These results support the notion that these two antileukemic cytidine analogs may have different mechanisms of action in exerting their antiproliferative activity.
Snyder
R D
RD
Merrell Dow Research Institute, Cincinnati, OH 45215.
Lachmann
P J
PJ
D000970:Antineoplastic Agents / Q000633:toxicity*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects* / Q000528:radiation effects; D004249:DNA Damage; D004260:DNA Repair / Q000187:drug effects*; D004277:DNA, Single-Stranded / Q000187:drug effects; D000077209:Decitabine; D006367:HeLa Cells; D006801:Humans; D009705:Nucleosides / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D004277:DNA, Single-Stranded; D009705:Nucleosides; D000077209:Decitabine; D001374:Azacitidine